Agoracom Blog Home

Posts Tagged ‘CSE’

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Provides BioCloud Update and Enters into Distribution Agreements $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 8:14 AM on Wednesday, November 18th, 2020
kontrol-logo

Safe Space Technology

  • Company intends to sell BioCloud directly to various potential customers. At the same time the Company is pursuing both exclusive and non-exclusive distribution channels for BioCloud sales
  • Entered into two non-exclusive BioCloud distribution agreements
  • Distribution agreements cover Ontario and Saskatchewan
  • Kontrol Energy Corp. is in the process of changing its name to Kontrol Technologies Inc.
  • The name change is anticipated to take place by the end of December 2020
  • As of November 17, 2020, the Company has $3.8 Million of cash on hand

TORONTO, ON / November 18, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on its BioCloud technology development.

“Our team continues to execute on the vision to create and bring to market a safe space technology,” says Paul Ghezzi, CEO of Kontrol.

Distribution Agreements

The Company intends to sell BioCloud directly to various potential customers. At the same time the Company is pursuing both exclusive and non-exclusive distribution channels for BioCloud sales. Kontrol is pleased to announce it has entered into two non-exclusive BioCloud distribution agreements. The distribution agreements cover Ontario and Saskatchewan.

The Company has also entered into discussions with various parties for potential industry exclusive distribution agreements which would require minimum unit quantity orders.

New Website

Kontrol has launched a new website for BioCloud. For more information please visit www.kontrolbiocloud.com.

Name Change

Kontrol Energy Corp. is in the process of changing its name to Kontrol Technologies Inc. The name change is anticipated to take place by the end of December 2020.

Cash on Hand

As of November 17, 2020, the Company has $3.8 Million of cash on hand.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others

BioCloud is not a medical device and the Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB: KNRLF)(FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

Loop Insights $MTRX.ca $RACMF Selected to Join Impact Radius Marketplace to Connect Leading Global Brands With Insights Customers and Build Additional Revenue Streams $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:18 AM on Wednesday, November 18th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the Company has been selected to join the Impact Radius Marketplace
  • Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy
  • Impact accelerates enterprise growth by automating the full partnership lifecycle for enterprise partnerships, with its Partnership Cloud™ managing over $50B in e-commerce sales and processing over $2B per year in payments to partners
  • Provides Loop with the opportunity to connect with and leverage marketing opportunities with Impact global brand partners such as Fanatics, Uber, Nike, Adidas, Airbnb, Levi’s and many more

VANCOUVER, British Columbia, Nov. 18, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected to join the Impact Radius Marketplace (“Impact”), providing Loop with the opportunity to connect with and leverage marketing opportunities with Impact global brand partners such as Fanatics, Uber, Nike, Adidas, Airbnb, Levi’s and many more.

IMPACT RADIUS IS THE GLOBAL LEADER IN PARTNERSHIP AUTOMATION MANAGING OVER $50 BILLION IN E-COMMERCE SALES

Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy. Impact accelerates enterprise growth by automating the full partnership lifecycle for enterprise partnerships, with its Partnership Cloud™ managing over $50B in e-commerce sales and processing over $2B per year in payments to partners.

As a result of its enterprise focus, Impact follows a rigorous selection process. In evaluating and eventually selecting Loop, Impact assessed both the opportunity Loop could provide brand partners with millions of potential users, as well as, the data Loop could provide to brands and the ability to deliver real-time activations to sports fans both at venues and at home.

Loop Insights CEO Rob Anson stated : “Selection into the Impact Radius marketplace is another strong vote of confidence for Loop as we continue to grow our client base. The Impact Radius marketplace will provide Loop with access to leading brands from around the world who will be discovering our anticipated massive venue audiences, AI analytics, real-time engagement, and verified reviews for the very first time. We look forward to providing these brands with never before seen opportunities to create new revenue streams with Loop.”

PAVING THE LAST MILE TO THE CUSTOMER IS THE NEXT STAGE OF ENTERPRISE GROWTH

A commissioned study conducted by Forrester Consulting in 2020 on behalf of Impact Radius determined that companies with well-developed partnership programs grow faster and outperform their low-maturity peers on a number of key business metrics.

Specifically, clients of Impact are generating up to 25% of total enterprise revenue through partnerships, with partnership revenue as a channel growing by 50% or more year over year.

“With over 75% of world trade flowing indirectly, Forrester believes the third stage of enterprise growth will revolve around paving the last mile to the customer through partners and alliances.” (Jay McBain, Forrester, Principal Analyst Global Channels)

LOOP POSITIONED TO DRIVE AFFILIATE MARKETING OPPORTUNITIES, NEW REVENUE STREAMS THROUGH RETAIL INSIGHTS AND ENGAGEMENT PLATFORM

Through its AI-driven retail analytics and insights platform, Loop Insights is positioning itself to become a significant player in the e-commerce and affiliate marketing space. Placement in the Impact Radius marketplace will allow Loop to generate revenue through global brand affiliate marketing programs delivered directly to consumers through the Company’s Wallet pass technology.

By enabling direct-to-consumer (DTC) brand affiliate relationships, Loop will provide brands with new targeted marketing opportunities through AI-driven analytics and insights. The Company expects to generate high conversion rates for brands through its retail insights platform, which will drive brand engagement, clicks, and sales while also generating revenue for Loop, which receives up to 10% per retail transaction.

As announced in a press release dated November 12, 2020, Loop Insights’ Uklipz platform will allow the Company to provide additional marketing opportunities to Impact Radius clients through verified video reviews created by consumers. The reviews can then be purchased or analyzed by brands and retailers to drive further engagement and sales.

The Company is exceptionally confident our complete solution from DTC access to AI analytics to verified reviews will provide Impact global brand customers with a compelling new channel.

LOOP SELECTION TO IMPACT MARKETPLACE DELIVERS SIGNIFICANT VALUE TO CURRENT AND PROSPECTIVE CLIENTS

Moreover, Loop’s inclusion in the Impact Radius marketplace will deliver significant value to our own clients through optimized marketing opportunities. By gaining access to the Impact Radius marketplace, Loop will advance revenue-generating opportunities for both the Company and its expanding list of clients. Loop’s retail engagement platform offers direct 1:1 marketing opportunities to brands, providing both Loop and its client base with additional revenue streams at each purchase point.

Loop is set to showcase its affiliate marketing integration with its Engage service during the NCAA #BeachBubble in Fort Myers, Florida. Attendees using their All Access Wallet Pass for venue tracing will also receive personalized discounts and promotions tailored to the event. This will combine the safety and security of end-to-end rapid testing and notifications with enhanced personalized user engagement demonstrating Loop’s full solution stack during a live event.

According to TrueList, more than 80% of brands offer affiliate marketing programs today, with Affiliate Marketing responsible for 16% of global e-commerce sales.

According to Statista, affiliate marketing just in the USA is expected to generate almost $USD 9 Billion by 2022.

This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights

About Impact Radius

Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy. Impact accelerates enterprise growth by automating the full partnership lifecycle, including discovery, recruitment, contracting, engagement, fraud protection, optimization, and payment processing for enterprise partnerships. Impact’s Partnership Cloud™ manages over $50B in e-commerce sales and processes over $2B per year in payments to partners. Impact drives revenue growth for global enterprise brands such as Bass Pro Shops, Fanatics, Getty Images, Lenovo, Levi’s, Techstyle, and Ticketmaster. Founded in Santa Barbara, CA in 2008, Impact has grown to over 500 employees worldwide.

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact:
Loop Insights Inc.LOOP Website : www.loopinsights.ai
Rob Anson , CEOFacebook: @LoopInsights
T : +1 877-754-5336 Ext. 4Twitter: @LoopInsights
E : [email protected]LinkedIn: @LoopInsights

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Binovi $VISN.ca $BNVIF Closes Private Placement of $2.05 Million $EYPT $KALA $PTON

Posted by AGORACOM-JC at 6:45 PM on Tuesday, November 17th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000
  • The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company and one common share purchase warrant

TORONTO, ON and NEW YORK, NY / November 17, 2020 / Binovi Technologies Corp., (Binovi) (TSXV:VISN)(OTCQB:BNVIF), a leader in neuro-vision performance technology, is pleased to announce it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000 (the “Private Placement”). The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company (a “Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Share (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share at any time until November 16, 2022. The warrants are subject to an acceleration clause whereby if the common share price is equal to or greater than $0.45 for a period of 5 consecutive trading days (at any time at or following the expiry of the four months resale restriction period), the Company may, by notice to the warrant holder reduce the remaining exercise period applicable to the warrants to not less than 30 days from the date of such notice.

The Company paid aggregate finder’s fees of $21,274.65 in cash and 166,860 finder’s warrants, with each finder warrant having the same terms as the Warrants.

The securities issued in connection with the Private Placement are subject to a four-month hold period expiring on March 18, 2021. Further restrictions may apply to certain subscribers under foreign securities laws.

Insiders participated in the Private Placement acquiring an aggregate of 2,284,314 units on the same basis as other subscribers. The participation in the Private Placement by insiders of the Company constitutes a “related party transaction” as such term is defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority approval requirements under MI 61-101. The Company relied on Section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the private placement in so far as the private placement involved interested parties did not exceed 25% of the Company’s market capitalization.

The Company intends to use the net proceeds from the Private Placement for general working capital.

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 20 countries.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CLIENT FEATURE: Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Technology To Detect #COVID-19 In The Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 2:25 PM on Tuesday, November 17th, 2020
kontrol-logo

Kontrol Energy is the Google NEST of smart building technology, with a Blue Chip client base to prove it with the likes of Beyond Meat, Toyota, Oxford, Telus and Brookfield to name a few.

As a result, Kontrol is already achieving commercial success as follows:

  • Q1 $2.3M
  • Q2 $2.7M

TOTAL Q1 AND Q2

  • REVENUE                 $5M
  • GROSS PROFIT        $2.7M

ADAPTING CORE TECH TO PROVIDE BLUE CHIP CUSTOMERS WITH REAL-TIME AIR DETECTION OF COVID-19 IN COMMERCIAL BUILDINGS

As a result of the COVID-19 pandemic and the needs of its blue chip customer base, Kontrol is adapting its core technologies team to development and commercialize its Kontrol BioCloud® analyzer, a wall-mounted technology which detects the presence of COVID-19 in the air of commercial buildings and triggers an alert system to provide real time notifications.

GEARING UP PRODUCTION FOR UP TO 20,000 UNITS PER MONTH

Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for areas such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals. The company is currently building a global supply chain with the goal of being able to supply 20,000 units per month.

The implications of the Kontrol BioCloud® analyzer could be enormous and could have a major impact on the global economy. Paul Ghezzi, CEO of Kontrol Energy has received calls from interested parties spanning the entire globe. In addition, mainstream media has taken notice:

Early tests suggest new Canadian technology could detect the coronavirus in the air Read More

Canadian firm develops tech to ‘detect COVID-19 in the air’; stock doubles Read More.

Kontrol Energy’s BioCloud Featured By Singapore’s IBI Times Read More

CSA APPROVAL RECEIVED ON NOVEMBER 5TH

On Novebmer 5th, KNR announced receipt of CSA standards approval for its BioCloud® technology.

“This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol. “CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively.”

UL STANDARDS APPROVAL RECEIVED NOVEMBER 12TH

“We continue to execute on the important milestones for commercialization of BioCloud,” says Paul Ghezzi, CEO of Kontrol. “With CSA and UL we now have standards approval that covers Canada, the United States and various other global regions. We continue to work towards CE standards certification which is primarily for the European market.”

DISCLAIMER: The Company has not made any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

For more information about the company, please check out the Kontrol Energy hub on AGORACOM.

FULL DISCLOSURE: Kontrol Energy is an advertising client of AGORA Internet Relations Corp.

Binovi $VISN.ca $BNVIF Appoints Dr. Susan Barry to the Binovi Scientific Advisory Board $EYPT $KALA $PTON

Posted by AGORACOM-JC at 9:39 AM on Tuesday, November 17th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Announced the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements
  • “Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO. 

November 17, 2020 Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) ( OTC:BNVIF) is proud to announce the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements. 

“Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO. 

“It is a distinct privilege to have Dr. Barry join our Scientific Advisory Board,” said Dr. Leonard Press, Chief Scientific Officer. “Her unique blend of insights and communication skills that crosses many lines between educators, eyecare professionals, researchers and the public is a tremendous asset to Binovi.” 

” Children struggling in school, adults recovering from a stroke, and athletes seeking to improve their game may all benefit from vision therapy. Its effects are often life-changing. I am looking forward to working with the Binovi team to develop new training techniques, explore the science behind vision therapy, and make vision therapy more accessible worldwide,” commented Dr. Susan R Barry, Ph.D. 

About Dr. Susan Barry 

Susan R. Barry, Ph.D. is an educator, scientist, and author who has spoken worldwide on the topics of neuroplasticity and binocular vision. She earned her B.A. in biology from Wesleyan University in 1976 and Ph.D. in biology from Princeton University in 1981. She has worked as a research neuroscientist at the University of Miami Medical School, the University of Michigan, the Marine Biological Laboratory, and NASA’s Johnson Space Center and published papers on synaptic transmission and eye-head-hand coordination. In 1992, she joined the faculty of Mount Holyoke College where she rose to the rank of full professor, retiring from the college in 2016. The Princeton Review lists Barry among the 300 outstanding college teachers in the U.S., her paper on the work of Frederick W. Brock was selected as the best published paper in the Journal of Behavioral Optometry in 2011, and in 2013 she received the Meribeth E. Cameron Faculty Award for Scholarship from Mount Holyoke College. 

For years, Barry taught her neurobiology students the conventional scientific wisdom that stereovision could develop only during a critical period in early childhood. She even used her own vision history to support this dogma since she had been cross-eyed since early infancy and was stereoblind. However, at age forty-eight, she consulted a developmental optometrist who prescribed a program of optometric vision therapy. To her utter astonishment, her vision improved dramatically, and she experienced her first 3D views. Dubbed “Stereo Sue” by Oliver Sacks in a 2006 New Yorker article by that name, Dr. Barry has gone on to write her own book Fixing My Gaze: A Scientist’s Journey into Seeing in Three Dimensions (Basic Books, 2009) which was rated the fourth best science book for 2009 by the editors of Amazon.com, selected as one of the best sci-tech books of 2009 by the Library Journal, and has been translated into seven languages. Barry’s second book, Coming to Our Senses: A Boy Who Learned to See, A Girl Who Learned to Hear, and How We All Discover the World , will be published by Basic Books in the summer of 2021. 

For additional information on the Company, please visit https://www.binovi.com/investor-reports 

About Binovi Technologies Corp. 

Binovi is a best-in-class neuro-visual platform designed to test, analyze, track, and report on individual vision and cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Sports Performance testing and training, and other areas of specialized care. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries. 

Terry Booth 

Executive Chairman 

Adam Cegielski 

Founder | CEO 

Investor Relations 

Email: [email protected]

Toll-free: 1 (844) 866-6162 

https://www.binovi.com/investor-reports/

Forward looking information: 

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Red Light Holland $TRIP.ca Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology $SHRM.ca $RVV.ca $MMED $PLNT.ca

Posted by AGORACOM at 9:09 AM on Tuesday, November 17th, 2020
Red-Light-Holland-Square
  • RadixMotion will design and develop a digital care program for people exploring microdosing
  • The core of the digital care program is a privacy first iMicrodose Journal,
  • A web app where people can anonymously document their microdosing and receive data driven analytics that will help them make informed choices around their usage

Toronto, Ontario–(Newsfile Corp. – November 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“) is pleased to announce that via its Scarlette Lillie Science and Innovation division, it has engaged RadixMotion Inc. (“RadixMotion“), an immersive technology company based in the State of Delaware, to design and develop a digital care program for people exploring microdosing. The program will accompany customers from the first time they encounter iMicrodose products in Smartshops via the iMicrodose Media Information Centre (“iMIC“) with an educational interactive augmented reality app. The core of the digital care program is a privacy first iMicrodose Journal, a web app where people can anonymously document their microdosing and receive data driven analytics that will help them make informed choices around their usage. The app will use Radix Motion’s expertise in biometric human pose data to give people feedback on whether microdosing has measurable effects on reducing their physiological tension or influences other features of their body posture. People using the digital care program will be able to opt in to share their anonymous data with the wider community allowing for substantial advancements in research.

“As access to psychedelics grows we want to provide people with the support they need to make the most out of microdosing via digital health mechanisms, which now includes our iMicrodose digital care program,” said Todd Shapiro, the Chief Executive Officer and Director of the Company. “While other companies in the sector are focused on clinical trials which take years to prove out, this approach of Scarlette Lillie, our science and innovation division, can have immediate benefits. We want to be a part of understanding psilocybin usage now as the mental health crisis is rampant. Gatekeepers can be limiting. We believe in working with informed consumers who are willingly sharing their data.”

‘Digital Health’ is defined as the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make it more personalized and precise. Scarlette Lillie is pleased to continue their partnership with Sarah Hashkes, CEO of RadixMotion – who published the first academic paper using the Predictive Coding frameworks to explain what psychedelics do to brains – to create a personalized iMicrodose Journal, a web-based app where people will be able to document their psilocybin use and they will be able to opt in to share their anonymous important data with the community which can then potentially be shared with scientific and medical experts. Microdosing research is at its infancy and this data has huge potential to increase Scarlette Lillie’s understanding rapidly.

“We are excited that our expertise in neuroscience and immersive technology is giving people tools to understand themselves and promoting responsible use of psychedelics. Red Light Holland’s and Scarlette Lillie’s care for their customers is a beacon of hope in the emerging psychedelic market. The consent based approach this program is taking around customers’ data and communicating with customers, we believe, is revolutionary and we hope many companies will follow this example. We are also excited about the AR aspect where customers can receive inspirational messages based on the latest research on wellness when they aim the app at iMicrodose products,” said Sarah Hashkes, CEO of RadixMotion and Scarlette Lillie’s Scientific Advisor. “But where it gets really exciting, as a scientific researcher in psychedelics, is if people do trust us and opt in to share their anonymous data with the community we will have a data set that can take microdosing research to a whole new level. The journal will immediately provide people with analytics about their microdosing so they can find what works best for them, but in the long run, Scarlette Lillie can hopefully use this data, including the unique biometric human pose data, to potentially find out what works best for people all over the world.”

Scarlette Lillie Science and Innovation estimates the total cost for the iMicrodose Digital Care Program, including Augmented Reality for the in-store iMic centres and the iMicrodose web-app Journal to be approximately USD$85,000. The completion of the Augmented Reality for the in-store iMIC remains on pace, expected to be launched before the end of 2020 and the iMicrodose web-app Journal is expected to be completed by RadixMotion and available by the end of Q1 2021.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping, Including a Soon-To-Be Announced, National Major Grocery Chain $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 8:39 AM on Tuesday, November 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America. Else and KeHE have activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

EVENT: CSE Presents Tech Tuesdays: Israeli Technology Advancements Featuring InnoCan Pharma $INNO.ca $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 7:37 AM on Tuesday, November 17th, 2020
Innocan-Blog

Don’t Miss Tech Tuesdays: Israeli Technology Advancements

The CSE looks forward to co-hosting our next Tech Tuesdays showcase, Israeli Technology Advancements, with the Canada Israel Chamber of Commerce

Join us live on November 17th!

Check out the exciting list of featured speakers! 

Don’t miss out on this exclusive glimpse at the cutting-edge technologies hailing from Israel that are making waves internationally. 

Else Nutrition $BABY.ca $BABYF Commences First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:28 AM on Tuesday, November 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Novel, Plant-based Complete Nutrition for Toddlers to hit retail shelves in coming weeks
  • Now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S.. 
  • The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S.
  • This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

VANCOUVER, BC , Nov. 17, 2020  ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , is pleased to announce that as part of its mission to ensure its novel, plant-based toddler nutrition products will be accessible to health conscious families across North America , that it has now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S.. The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

“We are so pleased that Else will be available to consumers on their favourite store shelves in advance of the Christmas holiday,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are making strong headway now, adding brick and mortar as a core sales vertical, to be complemented by our already-growing e-commerce and Amazon business verticals. We continue to extend our appreciation to KeHE Distributors for its early support of our brand, and anticipate early success and aggressive listings in 2021, as we develop our core retail accounts,” she added.

KeHE Distributors has nearly 70 years of experience servicing store owners and today has a network of over 16 distribution centers across North America . KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America . Else Nutrition’s agreement with KeHE Distributors secures a retail distribution path of Else’s ground-breaking plant-based toddler nutrition products to thousands of store shelves in the United States , and millions of consumers seeking plant-based alternatives for their children.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AGORACOM Small Cap 60: Avicanna $AVCN.ca $AVCNF Medical #Cannabis Trusted By Physicians and Clinicians $TRUL.ca $ACB

Posted by AGORACOM-JC at 3:06 PM on Monday, November 16th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Aras Azadian Chief Executive Officer and Co-Founder of Avicanna discusses the company’s medical cannabis which is trusted by physicians and clinicians. Azadian states, “Only 5% of physicians are currently prescribing Cannabis.” He continues to explain that the medical community has been skeptical of Canadian Licensed producers. Avicanna provides medical and only medical, this bodes well with the medical community.